Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 21, 2024
April 8, 2024
48325e39-b445-4a53-8cc0-7483dcf3e352
Related Documents
Container Closure Systems for Human Drugs and Biological Products
Guidance DocumentAugust 13, 2026Center for Drug Evaluation and Research
Regulatory Considerations for Prescription Drug Use-Related Software
Guidance DocumentSeptember 19, 2023Center for Drug Evaluation and Research
Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products
Guidance DocumentFebruary 1, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.